Table of Contents

The impending crisis in CNS drug development.
Animal models and procedures for CNS disorders.
Pre-clinical antecedents to early human clinical trials.
Biomarkers and surrogate markers in drug development.
Neuroimaging and cognitive assessments in early drug development.
Bridging and CSF studies.
A case study from pre-clinical to early clinical trials.